Moderna stock jumps nearly 11% after BofA target lift; flu vaccine filing in focus
NEW YORK, January 6, 2026, 12:28 EST — Regular session Shares of Moderna Inc (MRNA.O) were up 10.7% at $35.60 in midday trading on Tuesday after BofA Global Research raised its price objective on the vaccine maker. The stock touched